- Home
- EYEN vs APDN Comparison
EYEN vs APDN Comparison
Compare EYEN & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- APDN
- Stock Information
- Founded
- EYEN 2014
- APDN 1983
- Country
- EYEN United States
- APDN United States
- Employees
- EYEN N/A
- APDN N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- EYEN Health Care
- APDN Consumer Discretionary
- Exchange
- EYEN Nasdaq
- APDN Nasdaq
- Market Cap
- EYEN 9.2M
- APDN 9.4M
- IPO Year
- EYEN 2018
- APDN N/A
- Fundamental
- Price
- EYEN $0.06
- APDN $0.19
- Analyst Decision
- EYEN Hold
- APDN Strong Buy
- Analyst Count
- EYEN 4
- APDN 1
- Target Price
- EYEN $2.00
- APDN $1.50
- AVG Volume (30 Days)
- EYEN 49.5M
- APDN 5.7M
- Earning Date
- EYEN 11-12-2024
- APDN 02-13-2025
- Dividend Yield
- EYEN N/A
- APDN N/A
- EPS Growth
- EYEN N/A
- APDN N/A
- EPS
- EYEN N/A
- APDN N/A
- Revenue
- EYEN $31,832.00
- APDN $3,431,420.00
- Revenue This Year
- EYEN $23,413.60
- APDN $54.72
- Revenue Next Year
- EYEN $400.98
- APDN N/A
- P/E Ratio
- EYEN N/A
- APDN N/A
- Revenue Growth
- EYEN 2557.10
- APDN N/A
- 52 Week Low
- EYEN $0.06
- APDN $0.12
- 52 Week High
- EYEN $2.57
- APDN $14.40
- Technical
- Relative Strength Index (RSI)
- EYEN 35.58
- APDN 47.03
- Support Level
- EYEN $0.06
- APDN $0.21
- Resistance Level
- EYEN $0.09
- APDN $0.25
- Average True Range (ATR)
- EYEN 0.03
- APDN 0.03
- MACD
- EYEN 0.00
- APDN -0.00
- Stochastic Oscillator
- EYEN 1.58
- APDN 26.75
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.